Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenues, net:        
Product $ 2,606,464 $ 2,161,753 $ 7,431,715 $ 5,481,365
Recurring 901,321 1,127,025 2,799,200 3,197,925
Total Net Revenue 3,507,785 3,288,778 10,230,915 8,679,290
Product 1,469,104 1,166,848 4,746,731 2,969,512
Recurring 263,068 292,264 799,748 858,988
Total Cost of Sales 1,732,172 1,459,112 5,546,479 3,828,500
Gross Profit 1,775,613 1,829,666 4,684,436 4,850,790
Operating Expenses:        
Research and development 306,559 251,089 895,992 732,154
Selling, general and administrative 1,578,464 1,009,814 4,845,408 3,937,522
Depreciation and amortization 64,731 63,265 193,578 197,341
Total Operating Expense 1,949,754 1,324,168 5,934,978 4,867,017
Income (Loss) from Operations (174,141) 505,498 (1,250,542) (16,227)
Interest income (expense), net (11,401) 7,712 (9,978) (57,611)
Gain on sale of product line 0 0 41,902 15,408
Total Other Income (Expense) (11,401) 7,712 31,924 (42,203)
Income (Loss) Before Provision for Income Taxes (185,542) 513,210 (1,218,618) (58,430)
Provision for Income Taxes 294,936 0 295,216 0
Net Income (Loss) (480,478) 513,210 (1,513,834) (58,430)
Accretion of preferred dividends and discount (556,351) (308,386) (857,237) (723,252)
Net income (loss) attributable to common stockholders $ (1,036,829) $ 204,824 $ (2,371,071) $ (781,682)
Net income (loss) per common share:        
Net loss attributable to common stockholders per common share - basic $ (0.01) $ 0.00 $ (0.02) $ 0.00
Net loss attributable to common stockholders per common share - diluted $ (0.01) $ 0.00 $ (0.02) $ 0.00
Weighted Average Common Shares Outstanding - basic 117,150,713 106,153,192 111,177,407 105,011,687
Weighted Average Common Shares Outstanding - diluted 117,150,713 107,611,189 111,177,407 105,011,687